Joana Vidigal
vidigaljoana.bsky.social
Joana Vidigal
@vidigaljoana.bsky.social
1K followers 240 following 43 posts
Studying small RNAs and Argonaute proteins in mammals using mouse genetics. Part time runner, full time mom of Best Kiddo Ever (BKE) https://ccr.cancer.gov/staff-directory/joana-a-vidigal
Posts Media Videos Starter Packs
Reposted by Joana Vidigal
🚨🚨🚨 Please repost
We are looking for postdocs to join our lab at NIH.
Apply:
www.nichd.nih.gov/research/atNICHD/Investigators/rocha/apply
Learn more about training at NIH :
www.training.nih.gov/research-tra...
Reposted by Joana Vidigal
A giant thank you to @drjz.bsky.social and @vidigaljoana.bsky.social! It takes a village to celebrate #RNAday
NIH had fun celebrating another #RNAday. Thanks to @vidigaljoana.bsky.social for organizing this great event and @slwolin.bsky.social for building a strong RNA community.
Reposted by Joana Vidigal
NIH had fun celebrating another #RNAday. Thanks to @vidigaljoana.bsky.social for organizing this great event and @slwolin.bsky.social for building a strong RNA community.
Reposted by Joana Vidigal
Unpause! I'm super happy to now be able to share the published version of our paper at Science Advances showing that:
1) active histone mods occur independently of transcription
2) transcription coordinates histone deacetylation at active promoters
www.science.org/doi/10.1126/...
RNA polymerase II coordinates histone deacetylation at active promoters
Transcription initiation limits histone acetylation and H2AZ incorporation at promoters.
www.science.org
Reposted by Joana Vidigal
My research group seeks a highly motivated Post-Bacc (or Tech). This position offers a unique opportunity to contribute to research on cleavage-inducing tiny RNAs (cityRNAs) to treat neurological and neuromuscular disorders, Cancer, Alzheimer's diseases, etc.
u.osu.edu/cbcundergrad...
Job Opportunity for Recent Graduates (Post-Bacc) | CBC Undergraduate Program
u.osu.edu
Together, our data show that Rtl1 is an essential mRNA cleavage target of AGO2 and suggest that the repurposing of a retrotransposon-Argonaute regulatory interaction contributed to the retention of AGO catalytic competence in mammals
And finally, if we restore silencing of Rtl1 in mutant endothelial cells, we can essentially rescue all the endothelial phenotypes we documented!
It is also an imprinted gene, expressed only from the paternal allele. The maternal allele expresses instead a cluster of miRNAs that overlap Rtl1 in an antisense manner.

And you guessed it: we can find Rtl1 cleavage products for these miRNAs in RNA from wild-type but not catalytic mutant animals
Who is Rtl1? It turns out it is a domesticated retrotransposon known to regulate endothelial cell function - these are the cells that line our vessels
Turns out that one of the up-regulated genes, Rtl1, has 10 (!!!) perfect binding sites for well-expressed miRNAs! 😱

This extent of complementarity is well known to trigger RNA cleavage by AGO2
This is also pretty obvious in expression profiles from these animals, which show numerous genes up-regulated, which are largely involved vasculature development
It turns out, there a lot more wrong with these animals than just anemia (check out the paper for all the things we found!)

For one thing, these animals have extensive vascular defects characterized by enlarged and leaky vessels
So clearly there are other important cleavage targets in mammals.

We set out to find who they were!
These are so far the only cleavage targets in mammals whose dysregulation was shown to cause phenotypes in AGO2 catalytic dead mice - a very strong anemia

And yet.... these animals also die a few hours after birth! For unknown reasons!
It is fair to say that we have been obsessed with mammalian Argonaute proteins in the lab, and particularly the ability of AGO2 to slice transcripts!

This activity is incredibly conserved, and yet we have a poor understanding of what it's regulatory functions are in mammals 🤔
Our final speaker of the day is Astrid Haase, who will tell us about RNA-guided genome protection
Next speaker is Katie McJunkin who will tell us about the developmentally timed decay of an essential miRNA family